Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jul 10, 2004
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 --
Jul 10, 2004
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 --
Jul 10, 2004
President Oncology Division
President Oncology Division Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 --
Jul 10, 2004
President Oncology Division
President Oncology Division Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Jul 10, 2004
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jul 10, 2004
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jul 10, 2004
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 450,000 --
Jul 10, 2004
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jul 10, 2004
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 21, 2004
President Oncology Division
President Oncology Division Open market or private purchase of non-derivative or derivative security 200 $5.39
Jun 21, 2004
President Oncology Division
President Oncology Division Open market or private purchase of non-derivative or derivative security 400 $5.40
Jun 21, 2004
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 1,000 $5.40
Jun 10, 2004
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 2,000 $6.75
Sep 12, 2003
President, Oncology Division
President, Oncology Division Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 --
Sep 12, 2003
VP,Finance, Strategic Planning
VP,Finance, Strategic Planning Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Sep 12, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Sep 12, 2003
Director, Ch, Pres. and Chief Exec. Off.
Director, Ch, Pres. and Chief Exec. Off. Grant, award or other acquisition pursuant to Rule 16b-3(d) 215,000 --
Sep 12, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Sep 05, 2003
Other
Other Grant, award or other acquisition pursuant to Rule 16b-3(d) 90,000 --
Sep 05, 2003
Director, Ch, Pres. and Chief Exec. Off.
Director, Ch, Pres. and Chief Exec. Off. Grant, award or other acquisition pursuant to Rule 16b-3(d) 225,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.